Product Information
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB is a generic product labeled by Burel Pharmaceuticals, LLC, priced at $0.5892 per EA under NDC 35573045602. Its NADAC has been published 178 times since Mar 29, 2023.
FDA first approved this application on Apr 7, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 50 mg/1; mg/1
Manufacturer
Burel Pharmaceuticals, LLCNDC
35573045602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITALApproval Type
Generic (ANDA)
FDA Application
ANDA214088FDA Approved
4/7/2022
TE Code
AA
On Market Since
12/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has been published 178 times since Mar 29, 2023, and over the history we have for it it has declined 50.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5892 per EA |
|---|---|
| All-time high | $1.1810 (Apr 12, 2023) |
| All-time low | $0.4121 (Nov 20, 2024) |
| 52-week high | $0.7122 |
| 52-week low | $0.5411 |
| Median price | $0.6632 |
| Average price | $0.7272 |
| Largest weekly change | +39.8% (Sep 20, 2023) |
| Weeks tracked | 178 |
| Tracking since | Mar 29, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, manufactured by Burel Pharmaceuticals, LLC, is $0.5892 per EA (NDC 35573045602), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has declined 50.1%. It has been tracked across 178 weekly CMS publications since Mar 29, 2023.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
Since Mar 29, 2023, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has ranged from a low of $0.4121 (Nov 20, 2024) to a high of $1.1810 (Apr 12, 2023), with a median of $0.6632 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB (NDC 35573045602) is labeled by Burel Pharmaceuticals, LLC, and CMS classifies it as a generic product.